These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1186591)
1. [Elevated lead concentration in the blood during treatment with coumarin derivatives]. Loll H Med Lab (Stuttg); 1975 Aug; 28(8):177-9. PubMed ID: 1186591 [No Abstract] [Full Text] [Related]
2. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives. Gärtner BC; Seifert CB; Michalk DV; Roth B Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045 [TBL] [Abstract][Full Text] [Related]
3. [Lead concentration in blood during treatment with coumarin derivatives]. Fischer H; Wehran HI Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581 [No Abstract] [Full Text] [Related]
6. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives. Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944 [TBL] [Abstract][Full Text] [Related]
7. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services]. van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208 [TBL] [Abstract][Full Text] [Related]
9. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon. van Leeuwen Y; Rosendaal FR; van der Meer FJ Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321 [TBL] [Abstract][Full Text] [Related]
10. [The conus-cauda syndrome in occult ependymoma of the filum terminale with hemorrhagic infarction during anticoagulant therapy]. Manz F; Fantis A Nervenarzt; 1976 May; 47(5):338-9. PubMed ID: 1272497 [No Abstract] [Full Text] [Related]
11. [Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986]. Moskopp D; Brassel F; Ries F Klin Wochenschr; 1987 Aug; 65(16):781-90. PubMed ID: 3657042 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of coumarin-induced necrosis]. Meskó K; Katona K Schweiz Rundsch Med Prax; 1972 Jun; 61(26):861-4. PubMed ID: 4636080 [No Abstract] [Full Text] [Related]
14. [Drug interactions in coumarin anticoagulation]. Kessler P Vnitr Lek; 1999 Aug; 45(8):490-5. PubMed ID: 11045152 [TBL] [Abstract][Full Text] [Related]
15. Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogenetics. Brenner C; Huber B; Becker A; Ostermann H; Becker C; Steinbeck G; Franz WM Clin Genet; 2010 Nov; 78(5):499-501. PubMed ID: 21039429 [No Abstract] [Full Text] [Related]
16. [Mechanism of action of coumarin anti-coagulants (author's transl)]. Martius F Ther Umsch; 1977 May; 34(5):329-33. PubMed ID: 867312 [No Abstract] [Full Text] [Related]
17. [Antihemorrhagic activity of vitamin K 1. (Experimental and clinical results of its use in hemorrhages caused by coumarins]. Iriarte Ezcurdia JA; Babio San Salvador JL Rev Clin Esp; 1966 Jul; 102(1):26-8. PubMed ID: 5919713 [No Abstract] [Full Text] [Related]